Key result
Continuous aspirin therapy plus a powerful proton pump inhibitor is the treatment of choice for antiplatelet-related peptic ulcers, requiring individual evaluation of cardiovascular and gastrointestinal risks.
In patients requiring continuous antiplatelet therapy, gastrointestinal risk factors should be evaluated and managed, with PPIs recommended for the prevention and treatment of antiplatelet-related peptic ulcers.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Young Woon Chang (2014) conducted a review in Antiplatelet-related peptic ulcer disease. Antiplatelet therapy and Proton Pump Inhibitors was evaluated. Continuous aspirin therapy plus a powerful proton pump inhibitor is the treatment of choice for antiplatelet-related peptic ulcers, requiring individual evaluation of cardiovascular and gastrointestinal risks.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: